AGP Executive Report
Last update: an hour agoLife Sciences & Health: Oxeia Biopharma added US Navy Rear Admiral Don Plummer to its advisory board as military concussion injuries keep spotlighting the lack of FDA-approved treatments. Biotech Pipeline: GENFIT reported positive Phase 1b results for GNS561 plus a MEK inhibitor in heavily pretreated KRAS-mutated cholangiocarcinoma, with Phase 2 on track for 2H26. Transplant Tech: Lungpacer presented DONATE study results in Boston showing temporary transvenous phrenic nerve stimulation can improve donor lung suitability and increase lungs allocated for transplant. Corporate Deals: AbbVie agreed to buy Apogee Therapeutics for $10.9B, aiming to expand immunology and anti-inflammatory options. Aviation Tech: The FAA is partnering with Boston-based Airspace Intelligence to deploy AI tools to reduce flight delays, targeting full operation by end of 2028. Local Innovation: Avancell leased 128,000 sq ft at IQHQ’s Innovation Park in Andover for future commercial cancer drug production. Policy: The Senate passed a bipartisan housing bill to curb large institutional purchases of single-family homes and boost new construction. Data Centers: Forty mayors signed a pact to shape sustainable urban data center growth.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.